Clinical and Electroencephalographic Assessment of Cefepime During Treatment of Nosocomial Infections in Neurological Patients

Central Nervous System Agents in Medicinal Chemistry

Volumn 11, Issue 3, 2011, Pages 223-227

  Alvarez, Susana Dimas ^a   del Carmen Fernández Gonzalez Aragon, Maria ^a   Moreno, Alvaro ^a   Palomares Alonso, Francisca ^a   Cook, Helgi Jung ^a   Cárdenas, Graciela ^a   Soto Hernández, José Luis ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Cefepime; EEG; Myoclonus; Neurotoxicity; Plasma concentration; Seizures

Indexed keywords

CEFEPIME;

ADULT; ARTICLE; BACTERIAL MENINGITIS; BRAIN TUMOR; CEREBROSPINAL FLUID FISTULA; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTINUOUS INFUSION; ELECTROENCEPHALOGRAPHY; FEMALE; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; MALE; NEUROTOXICITY; PILOT STUDY; PNEUMONIA; POLYNEUROPATHY; SURGICAL INFECTION;

EID: 80055109458     PISSN: 18715249     EISSN: 18756166     Source Type: Journal    
DOI: 10.2174/187152411798047799     Document Type: Article

References (21)

1. Fung-Tomc, J.; Dougherty, T.J.; DeOrio, F.J.; Simich-Jacobson, V.; Kessler, R.E. Activity of cefepime against ceftazidime and ce-fotaxime-resistant Gram-negative bacteria and its relationship to beta-lactamase levels. Antimicrob. Agents Chemother., 1989, 33(4), 498-502.
2. Oster, S.; Edelstein, H.; Cassano, K.; McCabe, R. Open trial of cefepime (BMY 28142) for infections in hospitalized patients. An-timicrob. Agents Chemother., 1990, 34(6), 954-957.
3. Endimiani, A.; Perez, F.; Bonomo, R.A.; Cefepime: a reappraisal in an era of increasing antimicrobial resistance. Expert Rev. Anti Infect. Ther., 2008, 6(6), 805-824.
4. Tunkel, A.R.; Hartman, B.J.; Kaplan, S.L.; Kaufman, B.A.; Roos, K.L.; Scheld, W.M.; Whitley, R.J. Practice guidelines for the management of bacterial meningitis. Clin. Infect. Dis., 2004, 39(9), 1267-1284.
5. Fishbain, J.T.; Monahan, T.P.; Canonico, M.M. Cerebral manifestations of cefepime toxicity in a dialysis patient. Neurology, 2000, 55(11), 1756-1757
6. Dixit, S.; Kurle, P.; Buyan-Dent, L.; Sheth R.D. Status epilepticus associated with cefepime. Neurology, 2000, 54(11), 2153-2155.
7. Martínez-Rodríguez, J.E.; Barriga, F.J.; Santamaria, J.; Iranzo, A.; Pareja, J.A.; Revilla, M.; dela Rosa C.R. Nonconvulsive status epi-lepticus associated with cephalosporins in patients with renal failure. Am. J. Med., 2001, 111(2), 115-119.
8. Sonck, J.; Laureys, G.; Verbeelen, D. The neurotoxicity and safety of treatment with cefepime in patients with renal failure. Nephrol. Dial. Transplant., 2008, 23(3), 966-970.
9. Chatellier, D.; Jourdain, M.; Mangalaboyi, J.; Ader, F.; Chopin, C.; Derambure, P.; Fourrier, F. Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure. Intensive Care Med., 2002, 28(2), 214-217.
10. Burgess, D.S.; Hastings, R.W.; Hardin, T.C. Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion. Clin. Ther., 2000, 22(1), 66-75.
11. Han, E.E.; Beringer, P.M.; Falck, P.; Louie, S.; Rao, P.; Shapiro, B.; Gill, M. Pilot study of continuous infusion cefepime in adult patients with cystic fibrosis. J. Antimicrob. Chemother., 2006, 57(5), 1017-1019.
12. Roos, J.F.; Bulitta, J.; Lipman, J.; Kirkpatrick, C.M. Pharmacokine-tic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units. J. Antimicrob. Chemother., 2006, 58(5), 987-993.
13. Horan, T.C.; Andrus, M.; Dudeck, M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control, 2008, 36(5), 309-332.
14. Crum, R.M.; Anthony, J.C.; Bassett, S.S.; Folstein, M.F. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA, 1993, 269(18), 2386-2391.
15. Jiménez, P.F.; Callejón, M.M.; Jimenez, S.J.C.; Bello, L.M.A.; Guiraum, P.A. Validation of an HPLC method for determination of cefepime (a fourth-generation cephalosporin). Determination in human serum, cerebrospinal fluid, and urine. Pharmacokinetic profiles. Chromatographia, 2005, 62(7-8), 355-361.
16. Bragatti, J.A.; Rossato, R.; Ziomkowski, S.; Kliemann, F.A. Ce-fepime-induced encephalopathy: clinical and electroencephalo-graphic features in seven patients. Arq. Neuropsiquiatr., 2005, 63(1), 87-92.
17. De Silva, D.A.; Pan, A.B.; Lim, S.H. Cefepime-induced encepha-lopathy with triphasic waves in three Asian patients. Ann. Acad. Med. Singapore, 2007, 36(6), 450-451.
18. Lamoth, F.; Buclin, T.; Pascual, A.; Vora, S.; Bolay, S.; Decosterd, L.A.; Calandra, T.; Marchetti, O. High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function. Antimicrob. Agents. Che-mother., 2010, 54(10), 4360-4367.
19. Sugimoto, M.; Uchida, I.; Mashimo, T.; Yamazaki, S.; Hatano, K.; Ikeda, F.; Mochizuki, Y. Terai, T.; Matsuoka, N. Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins. Neuropharmacology, 2003, 45(3), 304-314.
20. Bragatti, J.A. Cefepime-induced neurotoxicity. Cent. Nerv. Syst. Agents Med. Chem., 2008, 8(4), 229-233.
21. Wang, J.F.; Wang, Q.; Zhao, L.H.; Shi, G.Z.; Zhou, J.X. Blood-brain barrier penetration of cefepime after neurosurgery. Chin. Med. J. (Engl.), 2007, 120(13), 1176-1178.